CLINICAL USE OF INTERMEDIATE TO HIGH-DOSE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA

被引：2
|
作者：
TAKASHIMA, Y [1 ]
机构：
[1] MEIJO HOSP,PEDIAT CLIN,FEDERAT NATL PUBL SERV PERSONNEL MUTUAL AID ASSOC,NAKA KU,NAGOYA 460,JAPAN
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 28卷 / 04期
关键词：
D O I：
10.1002/j.1552-4604.1988.tb03158.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：356 / 362
页数：7
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH ACUTE-LEUKEMIA
    UEDA, T
    NAKAMURA, T
    ANDO, S
    KAGAWA, D
    SASADA, M
    UCHINO, H
    JOHNO, I
    AKIYAMA, Y
    CANCER RESEARCH, 1983, 43 (07) : 3412 - 3416
  • [2] PLASMA AND LEUKEMIC-CELL PHARMACOKINETICS OF HIGH-DOSE N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN ACUTE-LEUKEMIA PATIENTS
    YOSHIDA, T
    KOBAYASHI, K
    OKABE, Y
    OKUMURA, H
    MATANO, S
    KANNO, M
    TAKEDA, Y
    OHTAKE, S
    NAKAMURA, S
    MATUDA, T
    JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (01): : 52 - 59
  • [3] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS WITH N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    KIMURA, K
    OHNO, R
    AMAKI, I
    HATTORI, K
    HIROTA, Y
    HOSHINO, A
    ICHIMARU, M
    ITO, M
    KIMURA, I
    MAEKAWA, T
    MASAOKA, T
    NAKAMURA, T
    OGAWA, M
    OGURO, M
    OHTA, K
    OSAMURA, S
    SHIMOYAMA, M
    TAKAKU, F
    UZUKA, Y
    YAMADA, K
    CANCER, 1985, 56 (08) : 1913 - 1917
  • [4] PHARMACOKINETIC STUDIES OF INTERMEDIATE-DOSE TO HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA AND LYMPHOMA
    TAKASHIMA, Y
    MATSUYAMA, K
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (04): : 330 - 333
  • [5] PHASE-III STUDY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN ADULT ACUTE-LEUKEMIA -BH-AC-DMP THERAPY
    YAMADA, K
    SUZUKI, H
    KATO, Y
    ACTA HAEMATOLOGICA JAPONICA, 1980, 43 (06): : 1080 - 1085
  • [6] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    KIMURA, K
    OHNO, R
    AMAKI, I
    HATTORI, K
    HIROTA, Y
    HOSHINO, A
    ICHIMARU, M
    ITO, M
    KIMURA, I
    MAEKAWA, T
    MASAOKA, T
    NAKAMURA, T
    OGAWA, M
    OGURO, M
    OHTA, K
    OSAMURA, S
    SHIMOYAMA, M
    TAKAKU, F
    UZUKA, Y
    YAMADA, K
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1986, 3 (01): : 15 - 24
  • [7] PHASE I-II STUDY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    KIMURA, K
    YAMADA, K
    UZUKA, Y
    MAEKAWA, T
    TAKAKU, F
    SHIMOYAMA, M
    OGAWA, M
    AMAKI, I
    OSAMURA, S
    ITO, M
    SAKAI, Y
    OGURO, M
    HATTORI, K
    HOSHINO, A
    HIROTA, Y
    OHTA, K
    NAKAMURA, T
    MASAOKA, T
    KIMURA, I
    ICHIMARU, M
    RECENT RESULTS IN CANCER RESEARCH, 1981, 76 : 232 - 240
  • [8] BIOCHEMICAL PHARMACOLOGY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDHOOD ACUTE-LEUKEMIA
    AVRAMIS, VI
    BIENER, R
    KRAILO, M
    FINKLESTEIN, J
    ETTINGER, L
    WILLOUGHBY, M
    SIEGEL, SE
    HOLCENBERG, JS
    CANCER RESEARCH, 1987, 47 (24) : 6786 - 6792
  • [9] PRODUCTION OF N-4-SUCCINYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, A NOVEL METABOLITE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, IN MICE AND ITS BIOLOGICAL SIGNIFICANCE
    OHISHI, J
    KATAOKA, T
    TSUKAGOSHI, S
    SAKURAI, Y
    SHIBUKAWA, M
    KOBAYASHI, H
    CANCER RESEARCH, 1981, 41 (06) : 2501 - 2506
  • [10] CYTO-TOXICITY OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE THROUGH GRADUAL CONVERSION TO 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HELA-CELLS
    MAEHARA, Y
    KUSUMOTO, T
    SAKAGUCHI, Y
    KUSUMOTO, H
    ANAI, H
    SUGIMACHI, K
    ANTICANCER RESEARCH, 1989, 9 (01) : 41 - 44
12345